SPRY News

ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline

ARS PHARMACEUTICALS DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPRY

ARS PHARMACEUTICALS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY

Pomerantz LLP Reminds Shareholders with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit – SPRY

Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026 - Contact Levi & Korsinsky

Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Levi & Korsinsky Urges ARS Pharmaceuticals, Inc. (SPRY) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law

SPRY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?